The customer stated that an employee at the site miscarried after exposure to some reagent.The customer was concerned about exposure to the following reagents: ck creatine kinase liquid, acc.To ifcc (ck), bilt3 bilirubin total gen.3 (tbil), and the elecsys folate rbc assay (folrbc).These reagents were identified as having health hazard pictograms with hazard statements relating to risk of damage to fertility or the unborn child in product labeling (package insert).This medwatch will apply to the folrbc assay.Please refer to the following medwatch patient identifiers for the other mentioned products: (b)(6).No further patient details were provided and the date of the event was not provided.Additional details regarding the event and the patient have been requested in 2 follow-ups with the customer.Additional attempts to obtain more information will be made.Information regarding personal protective equipment use by the employee has been requested but not provided.Inhalation of the of the complained reagents is not likely due to high boiling points and low vapor pressure for the substances of concern.Transcutaneous absorption of the reagents could not be excluded, but skin contact should be prevented when safety instructions documented in product labeling are followed and personal protective equipment are worn by the user.The reagent 1 bottle of the folrbc reagent contains boric acid (0.1-1% w/w), which is documented as a hazardous substance.It was also noted the customer uses reagents from various other manufacturers.
|
The customer has 3 modular pre-analytics systems and each is connected to 3 modular analytics p module analyzers, 3 modular analytics e170 analyzers, 1 cobas 6000 c (501) module,1 cobas integra 800 analyzer, and 3 cobas c513 analyzers.The serial numbers of the analyzers were not provided.Aside from safety information documented in the material safety data sheet for each product, the operator is instructed to follow safety precautions provided in the operator's manual labeling.The safety precautions include: -when handling reagents or other solutions, exercise the precautions required for handling laboratory reagents.Be sure to wear protective equipment (such as goggles, gloves).- observe the cautions given in the package insert and observe the information given in the material safety data sheets available for roche diagnostics reagents and cleaning solutions.- be careful when removing open reagent packs from the instrument.They may contain residues of reagents.- avoid direct contact with cleancell m, sysclean, probewash m, or hitergent.- if a reagent, detergent or other working solution comes into contact with your skin, wash it off immediately with water and apply a disinfectant.Consult a physician.- observe the system safety labels illustrated in safety labels section of the system operator's manual.The customer did not provide any additional information in relation to the event.The cause of miscarriage remains unclear.With such limited information, no medical assessment was possible.The labeling of the reagents used by the customer followed international rules and indicated potentially toxic substances adequately.
|